Shruti Bhat PhD MBA Certified Lean Six Sigma Black Belt
  • Home

Pharmaceutical Product Development:

Working closely with her clients, ranging from small entrepreneurial life science companies to mid-size and growing  global corporations, Shruti aim's to achieve increased performance by improving the efficiency and effectiveness of a company’s key business operations.

She provides perspectives and tools on how to achieve strategic objectives through Portfolio Management  including development of new products, adjacent markets, break-through innovations, strategic tie-ups, brand acquisitions and patents, to rapidly translate ‘Good Ideas to Profits’- Consistently ! 


Shruti has expertise with leading development of:
+   Innovative (NCE) drug products.
+  Generics and OTC.
+  Novel drug delivery formulations.


Shruti also provides direction on generating CMC reports for successful regulatory filings to USFDA.
​

Drug Discovery & Innovative Product Development:

She has successfully led drug discovery, product development and commercialization programs for over 20 small molecules and peptide moieties. Shruti employs the most current technology, patent and regulatory knowledge coupled with effective business processes to accelerate products into market.

Shruti specializes in the entire spectrum of drug discovery and formulation design engineering-

shruti bhat, drug discovery expert, formulation expert


​Novel / Targeted Drug Delivery Systems:

Now more than ever, innovation  is the key to growth, to acquiring and sustaining competitive advantage and to building shareholder value  for long-term. An effective innovation strategy depends more  on an organization’s innovation processes, tools and culture than how much it spends on R&D.
 
Shruti’s innovation strategies customize client’s innovation portfolio to their needs, reduce time-to-market revenues as well as help clients define the role of innovation in their pursuit of growth.  Shruti’s services have helped clients increase the health of their innovation portfolio by improving the overall return on their innovation investments- ROII, by introducing Product differentiation. 
  
And, differentiation goes way beyond just a shift from ‘me too product’ to ‘novel product’ breakthroughs. True differentiation stems from the presence of carefully nurtured distinctive product capabilities/ attributes that endure and are  TOUGH TO COPY.



Video showcasing Shruti's patents.
Over 20 National and PCT Patents to her credit.

For list click here >>
Innovation, strategy consultant, shruti bhat
Challenging dosage forms developed by Dr. Shruti U Bhat
Novel and Specialty formulations developed:

Developed  over 500 Novel dosage form products comprising: 
  • Medicated Chewing Gums.
  • Mouth Dissolve Films.
  • Transdermal patches.
  • Dispersible, Chewable, Effervescent, Soluble tablets
  • Soft gelatin capsules.
  • Tablet - in- tablets.
  • Capsules with powder, granules, pellets, tablets.
  • Bi- / Tri- layered tablets.
  • ODT - Oro dispersible tablets
  • Extended / Controlled release MUPS (multi-unit particulate systems),
  • Dry Powder Inhalation capsules and devices.
  • Inhalations solutions
  • Nasal sprays and gels.
  • MDI- Metered dose inhalations.
  • Ocular gels.
  • Form- Fill- Seal (FFS) products.
  • Taste masked syrups using carriers (Ion-exchange resins, cyclodextrin, carbopol, methacrylates, cellulose etc).
  • Targeted delivery systems.
  • Medicated Bandages and Burn care products.
  • Platform Technologies such as buccal, colon, gastro retentive (GERD)
  • Osmotic tablets.
  • Liposome and Nanotechnology based delivery systems. 
  • Mucosal delivery systems of Peptide and other Bio-technology based drugs.


​Generic & OTC Product Development:

Shruti has developed more than 1200 Generic drug and OTC products belonging to 35 different therapeutic categories, in 25 different formulation categories currently being sold in 65 countries across the globe, including Canada, US, Europe, Africa, Brazil, India, CIS and GCC markets.

Shruti has spearheaded development of both vanilla and specialty generics encompassing- Tablets, capsules, pellets, inhalation liquids, eye drops, syrups, injections, suppositories, creams, lotions etc.

She employs a unique combination of "Technical Life Sciences" principles with "Business Process Improvement" principles such as Lean, Six Sigma, Kaizen, JIT, TQM, ISO, 5S etc. to develop products fast, cost-effective and accelerate launch into markets.

Besides product development, Shruti has designed generic product development laboratories and clinical manufacturing sites for-
Anti-Cancer, Biosimilars, Hormones, Peptides, Steroids  and  Antibiotic products.


Therapeutic areas worked with:
Cardiology
Cancer research (Oncology)
Neurology and Psychiatry
Peptides and Biosimilars
Antibiotics
Anti- Malarials
Anti- Retrovirals
TB care
Pain management (NSAIDS, morphine based)
Eye care
Diabetes (ID and type II)
Thyroid care
Bone care and Osteoporosis
Anti- Allergy
Cold, Cough and Flu medicines

Now more than ever, innovation  is the key to growth, to acquiring and sustaining competitive advantage and to building shareholder value  for long-term. An effective innovation strategy depends more  on an organization’s innovation processes, tools and culture than how much it spends on R&D.
 
Shruti’s innovation strategies customize client’s innovation portfolio to their needs, reduce time-to-market revenues as well as help clients define the role of innovation in their pursuit of growth. 

 

She provides perspectives and tools on how to achieve strategic objectives through Portfolio Management  including development of new products, adjacent markets, break-through innovations, strategic tie-ups, brand acquisitions and patents, to rapidly translate ‘Good Ideas to Profits’- Consistently !
 
Her approach to Portfolio development begins by diagnosing the client’s current innovation processes & results and then helping them build distinctive capabilities to drive future performance that would bring right products to market FASTER. 

  

Shruti keeps a comprehensive focus on both top-line and bottom-line (i.e. value-mix) levers, helps improve product competitiveness and drive increased profitability- 
 
  • By  focussing on the top-line, Shruti helps clients quantify and translate customer insights and needs into advantaged product concepts and feature sets- together with an understanding of the willingness of customers to pay for them. Advantaged products drive superior competitive positioning and that in-turn drives higher sales.  
  • While, bottom-line focus helps companies deliver advantaged products and features sets to customer at the lowest possible price. The goal is to reduce basic product or service ‘functional’ costs and then re-invest the savings  into product features and consistent quality attributes
    that create real and perceived value  in the minds of the customers.
 

​Shruti’s services have helped clients increase the health of their innovation portfolio by improving the overall return on their innovation investments- ROII, by introducing Product differentiation.

​And, differentiation goes way beyond just a shift from ‘me too product’ to ‘novel product’ breakthroughs. ​True differentiation stems from the presence of carefully nurtured distinctive product capabilities/ attributes that endure and are  TOUGH TO COPY.
© Copyright 2003- 2019 Dr. Shruti Bhat ALL RIGHTS RESERVED. See Terms and Conditions on this site usage.
Created by Macro2Micro Media